0.3374
price up icon0.81%   0.0027
after-market Dopo l'orario di chiusura: .35 0.0126 +3.73%
loading
Precedente Chiudi:
$0.3347
Aprire:
$0.3526
Volume 24 ore:
965.09K
Relative Volume:
0.80
Capitalizzazione di mercato:
$33.85M
Reddito:
$147.75M
Utile/perdita netta:
$-284.23M
Rapporto P/E:
-0.0995
EPS:
-3.39
Flusso di cassa netto:
$-317.54M
1 W Prestazione:
-0.35%
1M Prestazione:
-13.82%
6M Prestazione:
-71.88%
1 anno Prestazione:
-40.86%
Intervallo 1D:
Value
$0.33
$0.3526
Intervallo di 1 settimana:
Value
$0.18
$0.4245
Portata 52W:
Value
$0.18
$2.93

Fibrogen Inc Stock (FGEN) Company Profile

Name
Nome
Fibrogen Inc
Name
Telefono
415-978-1200
Name
Indirizzo
350 BAY STREET, SAN FRANCISCO, CA
Name
Dipendente
486
Name
Cinguettio
@FibroGenInc
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
FGEN's Discussions on Twitter

Confronta FGEN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
FGEN 0.3374 33.85M 147.75M -284.23M -317.54M -3.39
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-08-08 Downgrade BofA Securities Neutral → Underperform
2023-06-26 Downgrade BofA Securities Buy → Neutral
2023-06-26 Downgrade Raymond James Outperform → Mkt Perform
2023-06-26 Downgrade Stifel Buy → Hold
2023-06-26 Downgrade William Blair Outperform → Mkt Perform
2023-06-02 Aggiornamento Stifel Hold → Buy
2023-01-31 Aggiornamento William Blair Mkt Perform → Outperform
2023-01-26 Aggiornamento Raymond James Mkt Perform → Outperform
2023-01-05 Aggiornamento BofA Securities Neutral → Buy
2021-09-22 Downgrade Goldman Neutral → Sell
2021-08-20 Aggiornamento Raymond James Underperform → Mkt Perform
2021-07-16 Downgrade BofA Securities Buy → Neutral
2021-07-16 Downgrade Stifel Buy → Hold
2021-04-07 Downgrade H.C. Wainwright Buy → Neutral
2021-04-07 Downgrade Mizuho Buy → Neutral
2021-03-31 Aggiornamento BofA Securities Neutral → Buy
2021-03-02 Downgrade Jefferies Buy → Hold
2021-02-01 Iniziato H.C. Wainwright Buy
2020-10-26 Iniziato Raymond James Underperform
2020-07-10 Ripresa Stifel Buy
2020-05-01 Iniziato Cowen Market Perform
2020-04-27 Iniziato BofA/Merrill Neutral
2019-05-29 Ripresa Goldman Neutral
2019-05-10 Downgrade William Blair Outperform → Mkt Perform
2019-04-12 Iniziato Piper Jaffray Neutral
2019-02-11 Ripresa Stifel Buy
2018-12-19 Aggiornamento Citigroup Neutral → Buy
2017-08-08 Reiterato Leerink Partners Outperform
2017-08-08 Reiterato Stifel Buy
2017-07-21 Downgrade Goldman Buy → Neutral
2017-07-11 Iniziato Jefferies Buy
2016-02-11 Aggiornamento Credit Suisse Neutral → Outperform
2016-01-21 Iniziato Credit Suisse Neutral
2015-12-04 Iniziato Citigroup Buy
2015-09-23 Iniziato Lake Street Hold
2015-07-29 Iniziato Citigroup Buy
2015-07-20 Aggiornamento Goldman Neutral → Buy
2014-12-09 Iniziato Stifel Buy
Mostra tutto

Fibrogen Inc Borsa (FGEN) Ultime notizie

pulisher
Nov 16, 2024

StockNews.com Begins Coverage on FibroGen (NASDAQ:FGEN) - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Reduces Stake in FibroGen Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

FibroGen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

FGEN stock touches 52-week low at $0.19 amid market challenges - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen, Inc. (NASDAQ:FGEN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: FibroGen reports strong Q3 sales, advances in oncology pipeline - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen: Q3 Earnings Snapshot - mySA

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen (FGEN) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions By GuruFocus - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Cost Reductions - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

FibroGen Reports Strong Q3 Growth and Future Plans - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

FibroGen Inc earnings beat by $0.14, revenue topped estimates - Investing.com Australia

Nov 12, 2024
pulisher
Nov 12, 2024

FibroGen Inc (FGEN) Q3 2024 Earnings: Revenue Surges to $46.3M, EPS at $(0.17), Exceeding Estimates - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

FibroGen Q3 Revenue Surges 15% as China Sales Soar; Narrows Net Loss by 73% | FGEN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 07, 2024

FibroGen Inc (FGEN) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register

Nov 07, 2024
pulisher
Nov 04, 2024

FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewswire

Nov 04, 2024
pulisher
Oct 31, 2024

Metrics That Matter About FibroGen Inc (NASDAQ: FGEN) - Stocks Register

Oct 31, 2024
pulisher
Oct 29, 2024

FGEN stock touches 52-week low at $0.3 amid market challenges - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Little Excitement Around FibroGen, Inc.'s (NASDAQ:FGEN) Revenues As Shares Take 26% Pounding - Simply Wall St

Oct 29, 2024
pulisher
Oct 29, 2024

FibroGen (NASDAQ:FGEN) Coverage Initiated by Analysts at StockNews.com - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

FGEN stock touches 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 21, 2024

FibroGen (NASDAQ:FGEN) Research Coverage Started at StockNews.com - Defense World

Oct 21, 2024
pulisher
Oct 16, 2024

The growth track for FibroGen Inc (FGEN) has changed recently - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

Should investors be concerned about FibroGen Inc (FGEN)? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Cubist Systematic Strategies LLC Has $256,000 Stock Holdings in FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Oct 15, 2024
pulisher
Oct 14, 2024

Market Watch: FibroGen Inc (FGEN)’s Noteworthy Gain, Closing at 0.36 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

FibroGen Hits New 52-week High, What's Fuelling The Stock? - RTTNews

Oct 14, 2024
pulisher
Oct 14, 2024

Pulmonary Fibrosis Drug Market Size & Analysis By 2024 -2034 -Boehringer Ingelheim, Roche, FibroGen, Inc., Merck & Co., – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 12, 2024

Sei Investments Co. Purchases 41,442 Shares of FibroGen, Inc. (NASDAQ:FGEN) - Defense World

Oct 12, 2024
pulisher
Oct 12, 2024

Financial Review: FibroGen (NASDAQ:FGEN) and Oncotelic Therapeutics (OTCMKTS:OTLC) - Defense World

Oct 12, 2024
pulisher
Oct 11, 2024

FibroGen's US$6.2m Market Cap Fall Books Insider Losses - Simply Wall St

Oct 11, 2024
pulisher
Oct 10, 2024

FibroGen Inc [FGEN] Chief Medical Officer makes an insider acquire of 22,123 shares worth 25,884. - Knox Daily

Oct 10, 2024
pulisher
Oct 09, 2024

FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Investors in cash trouble should check out FibroGen Inc (FGEN) - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

FGEN stock touches 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

FGEN stock touches 52-week low at $0.33 amid market challenges - Investing.com Australia

Oct 08, 2024
pulisher
Oct 08, 2024

A year in review: FibroGen Inc (FGEN)’s performance in the last year - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

Trading Day Triumph: FibroGen Inc (FGEN) Ends at 0.37, a -8.07 Surge/Plunge - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

FibroGen Inc Inc. (FGEN) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 07, 2024
pulisher
Oct 07, 2024

Investing in FibroGen Inc (FGEN): What You Must Know - Knox Daily

Oct 07, 2024
pulisher
Oct 05, 2024

StockNews.com Initiates Coverage on FibroGen (NASDAQ:FGEN) - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

FibroGen will pay $10M to exit HQ lease in SF’s Mission Bay - The Real Deal

Oct 04, 2024
pulisher
Oct 03, 2024

FibroGen Suit Alleging Disclosure Failures Tossed In Del. - Law360

Oct 03, 2024

Fibrogen Inc Azioni (FGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):